Lifeward names Ronen Tsimerman as Chief Financial Officer
The Israeli company's board appointed Tsimerman effective November 1, 2026, following prior finance leadership roles at IceCure Medical and Scopio Labs.
SEC filing
Latest
1 story
Sign inSign in1 story
The Israeli company's board appointed Tsimerman effective November 1, 2026, following prior finance leadership roles at IceCure Medical and Scopio Labs.
SEC filing